Controlled Human Malaria Infection Transmission Model - Phase A

NCT04280692 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

SUSPENDED

Status

44

Enrollment

OTHER

Sponsor class

Stopped Study halted prematurely due to US FDA clinical hold on PfSPZ Challenge

Conditions

Malaria,Falciparum

Interventions

BIOLOGICAL: PfSPZ Challenge
DRUG: Sulfadoxine-Pyrimethamine
DRUG: Piperaquine
DRUG: Artemether lumefantrine
DRUG: Primaquine

Sponsor

University of Oxford

Collaborators

[object Object]
[object Object]
[object Object]